Transient ischemic
164 results
1 - 100- Non-pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack: Cochrane systematic review
- Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack
- Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack: Cochrane systematic review
- Oral anticoagulants for preventing stroke in patients with non‐valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
- Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks: Cochrane systematic review
- Transient ischaemic attack (TIA)
- Short-term clopidogrel + aspirin prevents second ischemic stroke better than aspirin alone
- Warfarin or antiplatelet therapy for stroke prevention in patients with non-valvular atrial fibrillation
- Fewer recurrent strokes but more bleeding with DAPT within 72 hours of mild ischemic stroke (INSPIRES)
- Anticoagulants for non-rheumatic atrial fibrillation and a history of stroke or transient ischaemic attacks
- Pioglitazone after stroke or TIA reduces stroke and MI, but has significant harms as well
- Clopidogrel + aspirin superior to aspirin alone following TIA or minor stroke
- Ticagrelor plus aspirin is superior to aspirin alone in preventing stroke after TIA or minor stroke (THALES)
- Dual antiplatelet therapy with either clopidogrel or ticagrelor is more effective than aspirin alone in preventing recurrent stroke
- Long-term increased mortality risk among adults aged 18 to 50 years after acute stroke
- AHA guideline for secondary stroke prevention
- High-dose atorvastatin reduces recurrent stroke, not mortality (SPARCL)
- Small reduction in CV outcome after ischemic stroke with lower LDL target, but also harms; no change in all-cause mortality
- Clopidogrel + aspirin provides more net benefit than aspirin alone after minor stroke or TIA
- Low rates of bleeding with both aspirin plus clopidogrel and aspirin alone after TIA or minor stroke
- Closing patent foramen ovale for cryptogenic stroke or TIA is not effective
- ABCD2 score not reliable for stroke prediction after TIA
- ABCD score predicts 7 day stroke risk in patients with TIA
- Risk of stroke after TIA is 2.8% at 1 month and 5.1% at 1 year
- Aggressive early tx after TIA/minor stroke improves outcomes (EXPRESS)
- ABCD rule predicts 7- and 30-day stroke risk in pts with TIA
- Closure of PFO similar to medical therapy for cryptogenic stroke or TIA
- Fewer recurrent strokes with PFO closure than medical treatment in patients with cryptogenic stroke
- Both benefits and harms for low-dose aspirin in patients with diabetes mellitus (ASCEND)
- Clopidogrel + 21 days ASA superior to ASA alone within first 24 hrs of TIA or minor stroke
- Triple antiplatelet tx increases bleeding and no better than standard therapy for preventing TIA and recurrent CVA (TARDIS)
- Nonfocal transient neurological attacks increase risk of future stroke and dementia
- Dual antiplatelet therapy is superior to aspirin in preventing short-term recurrent stroke at the cost of more major bleeding
- Postoperative and nonoperative atrial fibrillation associated with similar risks of stroke and death
- Pioglitazone associated with lower rate of stroke and MI in patients with prediabetes and recent stroke
- ABCD2 score not very reliable in predicting future stroke
- Warfarin for preventing stroke in patients with non-valvular atrial fibrillation and no history of cerebral ischaemia
- USPSTF 2021 reaffirms recommendation against screening for asymptomatic carotid artery stenosis (D recommendation)
- Early anticoagulation after ischemic stroke is a safe strategy (ELAN)
- Extracranial-intracranial bypass surgery does not reduce recurrent stroke risk
- ABC (Age, Biomarkers, Clinical history) score predicts stroke risk in atrial fibrillation
- Closure vs. medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or TIA
- Statins for acute ischemic stroke: Cochrane systematic review
- Low-dose aspirin not effective for primary prevention of CV events (again) and increases risk of serious bleeding
- No benefit to bypass surgery vs medical treatment for symptomatic carotid/cerebral artery occlusion/insufficiency (CMOSS)
- Increased GI bleeding after switch from warfarin to dabigatran
- Decreasing systolic BP to 130 or lower improves outcomes (CARDIO-CIS)
- Fewer subsequent strokes with ticagrelor plus aspirin than with aspirin alone
- BP goals in patients older than 60 years
- ASA+dipyridamole better than ASA for cerebral ischemia (ESPRIT)
- Prolonged monitoring more likely to detect AF after cryptogenic stroke